2021
Risk profiles for mental disorders
Gülöksüz S. Risk profiles for mental disorders. European Psychiatry 2021, 64: s71-s71. PMCID: PMC9471330, DOI: 10.1192/j.eurpsy.2021.220.Peer-Reviewed Original ResearchPsychiatric diagnosisSame psychiatric diagnosisDifferent psychiatric diagnosesSame treatment protocolClinical staging modelRisk profilingDiagnosis-specific treatmentsSame treatment planTreatment protocolTreatment responseMedical conditionsClinical practiceDiagnostic classification systemsTreatment planMental disordersStaging modelRisk profileDiscrete diagnostic categoriesPatientsDiagnostic categoriesClinical predictionDiagnosisEarly psychopathologyTraditional diagnostic boundariesPrognostication
2018
Evaluation of the Association between Lithium Treatment and GSK3β Polymorphism in Bipolar Disorder Patients.
Altınbaş K, Yeşilbaş D, İnce B, Cansız A, Sılan F, Özdemir Ö, Gülöksüz S. Evaluation of the Association between Lithium Treatment and GSK3β Polymorphism in Bipolar Disorder Patients. Turkish Journal Of Psychiatry 2018, 29: 73-78. PMID: 30215834, DOI: 10.5080/u20582.Peer-Reviewed Original ResearchConceptsMean ageLithium treatmentTreatment responseGSK-3βBipolar disorder type IBipolar disorder patientsLack of evidenceClinical predictorsHospital recordsTreatment adherenceTreatment optionsDisease onsetFirst episodeReal-time PCRIndividualized treatmentPharmacogenomic findingsBlood samplesDisorder patientsSide effectsAG genotypeClinical practiceScale scoreBipolar disorderPatientsSample cohort
2017
The experience sampling method as an mHealth tool to support self‐monitoring, self‐insight, and personalized health care in clinical practice
van Os J, Verhagen S, Marsman A, Peeters F, Bak M, Marcelis M, Drukker M, Reininghaus U, Jacobs N, Lataster T, Simons C, Investigators E, Lousberg R, Gülöksüz S, Leue C, Groot P, Viechtbauer W, Delespaul P. The experience sampling method as an mHealth tool to support self‐monitoring, self‐insight, and personalized health care in clinical practice. Depression And Anxiety 2017, 34: 481-493. PMID: 28544391, DOI: 10.1002/da.22647.Peer-Reviewed Original ResearchConceptsExperience sampling methodClinical practiceTrial of MindfulnessESM data collectionPersonalized trajectoriesEmotion dynamicsCognitive abilitiesRoutine clinical practiceDifferent patient groupsNatural rewardsRoutine outcome measurementDaily lifeBlended careMix of faceImplicit patternsMental healthSmartphone usePatient groupOffice treatmentTwin studiesOutcome measurementsProcess of diagnosisMHealth toolsTreatment evaluationDecision making
2013
721 – European psychiatric trainees and their interactions with the pharmaceutical industry: results from the efpt-prirs study
Riese F, Guloksuz S, Roventa C, Fair J, Haravuori H, Rolko T, Flynn D, Giacco D, Banjac V, Jovanovic N, Bayat N, Palumbo C, Rusaka M, Kilic O, Augėnaitė J, Nawka A, Zenger M, Kekin I, Wuyts P, Barrett E, Bausch-Becker N, Mikaliunas J, del Valle E, Feffer K, Lomax G, Marques J, Jauhar S. 721 – European psychiatric trainees and their interactions with the pharmaceutical industry: results from the efpt-prirs study. European Psychiatry 2013, 28: 1. DOI: 10.1016/s0924-9338(13)75941-8.Peer-Reviewed Original Research
2011
P03-79 - How do european psychiatry trainees prescribe when treating depression, and what influences decision-making? (Survey of the European Federation of Psychiatric Trainees Research Group)
Jauhar S, Guloksuz S, Marques J, Nawka A, Roventa C, Psaras R, Andlauer O, Lydall G, De Vriendt N, Mendonca L, Van Zanten J, Dumiterscu I, Nwachukwu I, Riese F, Group E. P03-79 - How do european psychiatry trainees prescribe when treating depression, and what influences decision-making? (Survey of the European Federation of Psychiatric Trainees Research Group). European Psychiatry 2011, 26: 1248. DOI: 10.1016/s0924-9338(11)72953-4.Peer-Reviewed Original ResearchSide effect profileClinical practiceChoice of antidepressantSevere depressive episodeAntidepressant medicationDepressive episodeTreatment choiceResponse rateAntidepressantsSimilar antidepressantsSubsequent guidelinesPatientsEvidence baseMinimum response rateGuideline suggestionsRecent evidenceMedicationsEuropean traineesPsychiatry traineesEfficacyLittle evidenceSample sizeTraineesFactorsRecent literature
2010
PW01-264 - How would European trainees treat bipolar disorder for their patients and themselves, and what influences decision-making?
Jauhar S, Lydall G, Riese F, Marques J, Bendix M, Andlauer O, Gerber S, De Vriendt N, Dumitrescu I, Nawka A, Guloksuz S, Mendonca L, Nwachukw I, Psaras R, Roventa C, Giacco D, Mufic A, Dobrzynska E, Nazaraliev A, Van Zanten J, Group E. PW01-264 - How would European trainees treat bipolar disorder for their patients and themselves, and what influences decision-making? European Psychiatry 2010, 25: 1596-1597. DOI: 10.1016/s0924-9338(10)71577-7.Peer-Reviewed Original ResearchP03-343 - Treatment choice in psychiatry? How would European trainees treat psychosis for their patients and themselves, and what influences decision-making?
Jauhar S, Guloksuz S, Marques J, Bendix M, Lydall G, Andlauer O, Gerber S, Roventa C, Van Zanten J, De Vriendt N, Nawka A, Nwachukw I, Dobrzynska E, Mufic A, Nazaraliev A, Dumitrescu I, Mendonca L, Riese F, Group E. P03-343 - Treatment choice in psychiatry? How would European trainees treat psychosis for their patients and themselves, and what influences decision-making? European Psychiatry 2010, 25: 958. DOI: 10.1016/s0924-9338(10)70949-4.Peer-Reviewed Original ResearchFirst-line therapySide effect profileTreatment choiceClinical practicePsychiatric clinical practiceEuropean traineesCATIE trialAntipsychotic medicationAntipsychoticsResponse ratePatientsEvidence baseMinimum response ratePsychosisRecent evidenceClozapineTherapyEfficacySample sizeTraineesPsychiatryMedicationsPrescribingFactorsResponders